• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解读雄激素在多囊卵巢综合征患者皮肤表现中的作用:最新综述

Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review.

作者信息

Taieb Ach, Feryel Amri

机构信息

Faculty of Medicine of Sousse, University of Sousse, Sousse 4000, Tunisia.

Department of Endocrinology, University Hospital of Farhat Hached Sousse, Sousse 4031, Tunisia.

出版信息

Diagnostics (Basel). 2024 Nov 16;14(22):2578. doi: 10.3390/diagnostics14222578.

DOI:10.3390/diagnostics14222578
PMID:39594244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11592971/
Abstract

Polycystic ovary syndrome is a presvalent endocrine disorder affecting women globally, characterized by hormonal imbalance, metabolic disturbances, and reproductive dysfunction. Diagnosis relies on clinical evaluation, medical history assessment, physical examination, and laboratory tests, with the Rotterdam criteria being widely used. The pathophysiology of PCOS involves genetic predisposition, environmental factors, and lifestyle influences, with hormonal dysregulation, particularly elevated androgens, insulin resistance, and chronic inflammation, playing a pivotal role. These mechanisms not only contribute to reproductive and metabolic disturbances but also to the various cutaneous manifestations, such as acne, hirsutism, and alopecia. This review aims to analyze the role of androgens in the dermatological manifestations in patients with polycystic ovary syndrome, providing insights into underlying mechanisms and guiding the development of effective therapeutic strategies. By synthesizing available evidence, this review aims to deepen understanding of related dermatological manifestations and improve outcomes for affected individuals.

摘要

多囊卵巢综合征是一种在全球范围内影响女性的常见内分泌疾病,其特征为激素失衡、代谢紊乱和生殖功能障碍。诊断依赖于临床评估、病史评估、体格检查和实验室检查,其中鹿特丹标准被广泛应用。多囊卵巢综合征的病理生理学涉及遗传易感性、环境因素和生活方式影响,激素失调,尤其是雄激素升高、胰岛素抵抗和慢性炎症起着关键作用。这些机制不仅导致生殖和代谢紊乱,还导致各种皮肤表现,如痤疮、多毛症和脱发。本综述旨在分析雄激素在多囊卵巢综合征患者皮肤表现中的作用,深入了解潜在机制并指导有效治疗策略的制定。通过综合现有证据,本综述旨在加深对相关皮肤表现的理解并改善受影响个体的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/43704b315151/diagnostics-14-02578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/3e5a06fde343/diagnostics-14-02578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/710e711a05d7/diagnostics-14-02578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/8efac63edd88/diagnostics-14-02578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/e558d5fa34b9/diagnostics-14-02578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/43704b315151/diagnostics-14-02578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/3e5a06fde343/diagnostics-14-02578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/710e711a05d7/diagnostics-14-02578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/8efac63edd88/diagnostics-14-02578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/e558d5fa34b9/diagnostics-14-02578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd49/11592971/43704b315151/diagnostics-14-02578-g005.jpg

相似文献

1
Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review.解读雄激素在多囊卵巢综合征患者皮肤表现中的作用:最新综述
Diagnostics (Basel). 2024 Nov 16;14(22):2578. doi: 10.3390/diagnostics14222578.
2
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南——第1部分。
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
3
Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.中国北方多囊卵巢综合征女性皮肤表现及代谢生物标志物的患病率
J Cosmet Dermatol. 2018 Jun;17(3):511-517. doi: 10.1111/jocd.12387. Epub 2017 Sep 21.
4
A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact.多囊卵巢综合征皮肤表现的叙述性综述:病理生理学、诊断、管理及社会心理影响
Ann Med Surg (Lond). 2025 Mar 28;87(5):2804-2811. doi: 10.1097/MS9.0000000000003217. eCollection 2025 May.
5
Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.韩国患者多囊卵巢综合征各亚型的皮肤表现
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):42-7. doi: 10.1111/jdv.12432. Epub 2014 Mar 14.
6
The Impact of Vitamin D Receptor Gene Polymorphisms () in Correlation with Oxidative Stress and Hormonal and Dermatologic Manifestations in Polycystic Ovary Syndrome.维生素 D 受体基因多态性与多囊卵巢综合征的氧化应激及激素和皮肤表现的相关性研究。
Medicina (Kaunas). 2024 Sep 14;60(9):1501. doi: 10.3390/medicina60091501.
7
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.多囊卵巢综合征女性的皮肤表现及全身相关情况。
JAMA Dermatol. 2016 Apr;152(4):391-8. doi: 10.1001/jamadermatol.2015.4498.
8
Characterizing clinical and hormonal profiles of acne in north African women with polycystic ovary syndrome.描述北非多囊卵巢综合征女性痤疮的临床和激素特征。
Arch Dermatol Res. 2024 Oct 26;316(10):711. doi: 10.1007/s00403-024-03466-3.
9
Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges.多囊卵巢综合征(PCOS)女性使用二甲双胍:机遇、益处及临床挑战。
Diabetes Obes Metab. 2025 Jun;27 Suppl 3(Suppl 3):31-47. doi: 10.1111/dom.16422. Epub 2025 May 6.
10
Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study.多囊卵巢综合征的皮肤表现:一项横断面临床研究。
Indian Dermatol Online J. 2017 Mar-Apr;8(2):104-110. doi: 10.4103/2229-5178.202275.

引用本文的文献

1
Relations of Insulin Resistance, Body Weight, Vitamin D Deficiency, SHBG and Androgen Levels in PCOS Patients.多囊卵巢综合征患者胰岛素抵抗、体重、维生素D缺乏、性激素结合球蛋白及雄激素水平之间的关系
Biomedicines. 2025 Jul 23;13(8):1803. doi: 10.3390/biomedicines13081803.
2
Clinical effectiveness of ethinylestradiol-cyproterone acetate and raloxifene combination therapy in polycystic ovary syndrome-associated infertility.炔雌醇-醋酸环丙孕酮与雷洛昔芬联合治疗多囊卵巢综合征相关性不孕症的临床疗效
Am J Transl Res. 2025 Jul 15;17(7):5081-5089. doi: 10.62347/ZUHL5679. eCollection 2025.
3
The Synergistic Effect of Autophagy and Apoptosis in Iraqi Women with Polycystic Ovary Syndrome.
自噬与凋亡在伊拉克多囊卵巢综合征女性中的协同作用
J Reprod Infertil. 2025 Jan-Mar;26(1):36-49. doi: 10.18502/jri.v26i1.18780.
4
Subclinical Hypothyroidism in Polycystic Ovary Syndrome: Prevalence and Impact on Metabolic and Cardiovascular risk.多囊卵巢综合征中的亚临床甲状腺功能减退:患病率及其对代谢和心血管风险的影响。
Clin Med Insights Endocrinol Diabetes. 2025 Jun 3;18:11795514251343678. doi: 10.1177/11795514251343678. eCollection 2025.
5
Differential Effects of Canonical Androgens and 11-Ketotestosterone on Reproductive Phenotypes and Folliculogenesis in Mouse Model of PCOS.经典雄激素和11-酮睾酮对多囊卵巢综合征小鼠模型生殖表型和卵泡发生的差异影响
Biomedicines. 2025 Apr 29;13(5):1077. doi: 10.3390/biomedicines13051077.
6
Skin Microbiota: Mediator of Interactions Between Metabolic Disorders and Cutaneous Health and Disease.皮肤微生物群:代谢紊乱与皮肤健康和疾病之间相互作用的调节者
Microorganisms. 2025 Jan 14;13(1):161. doi: 10.3390/microorganisms13010161.